Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus

被引:0
|
作者
FF Falcini
CS Capannini
MG Martini
LTF La Torre
VA Vitale
NF Nacci
MCM Matucci Cerinic
CR Cimaz
ZF Zulian
机构
[1] University of Florence,Department of Biomedicine, Division of Rheumatology, Transition Unit
[2] University of Padua,Department of Paediatrics, Rheumatology Unit
[3] University of Messina,Department of Paediatrics, Rheumatology Unit
[4] University of Florence,A. Meyer Children's Hospital, Rheumatology Unit
关键词
Steroid; Systemic Lupus Erythematosus; Renal Disease; Blood Count; Treatment Duration;
D O I
10.1186/1546-0096-6-S1-P234
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
    R Indaco
    M Alessio
    MR Caropreso
    G Malgieri
    C Pecoraro
    Pediatric Rheumatology, 6 (Suppl 1)
  • [22] Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus
    Doherty, T.
    Austin, S. K.
    Newell, B.
    Kiely, P. D. W.
    LUPUS, 2013, 22 (02) : 213 - 215
  • [23] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study
    Giani, Teresa
    Smith, Eve Md
    Al-Abadi, Eslam
    Armon, Kate
    Bailey, Kathryn
    Ciurtin, Coziana
    Davidson, Joyce
    Gardner-Medwin, Janet
    Haslam, Kirsty
    Hawley, Dan P.
    Leahy, Alice
    Leone, Valentina
    McErlane, Flora
    Mewar, Devesh
    Modgil, Gita
    Moots, Robert
    Pilkington, Clarissa
    Pregnolato, Francesca
    Ramanan, Athimalaipet, V
    Rangaraj, Satyapal
    Riley, Phil
    Sridhar, Arani
    Wilkinson, Nick
    Cimaz, Rolando
    Beresford, Michael W.
    Hedrich, Christian M.
    LUPUS, 2021, 30 (12) : 1955 - 1965
  • [24] Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil
    Ungprasert, P.
    Chowdhary, V. R.
    Davis, M. D.
    Makol, A.
    LUPUS, 2016, 25 (04) : 427 - 430
  • [25] Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis
    Smith, E. M. D.
    Al-Abadi, E.
    Armon, K.
    Bailey, K.
    Ciurtin, C.
    Davidson, J.
    Gardner-Medwin, J.
    Haslam, K.
    Hawley, D.
    Leahy, A.
    Leone, V.
    McErlane, F.
    Mewar, D.
    Modgil, G.
    Moots, R.
    Pilkington, C.
    Ramanan, A.
    Rangaraj, S.
    Riley, P.
    Sridhar, A.
    Wilkinson, N.
    Beresford, M. W.
    Hedrich, C. M.
    LUPUS, 2019, 28 (05) : 613 - 620
  • [26] Bone Health in Juvenile-Onset Systemic Lupus Erythematosus
    Chang, Caroline
    Pitukcheewanont, Pisit
    CURRENT RHEUMATOLOGY REVIEWS, 2012, 8 (03) : 199 - 208
  • [27] Rituximab therapy for juvenile-onset systemic lupus erythematosus
    Nwobi, Obioma
    Abitbol, Carolyn L.
    Chandar, Jayanthi
    Seeherunvong, Wacharee
    Zilleruelo, Gaston
    PEDIATRIC NEPHROLOGY, 2008, 23 (03) : 413 - 419
  • [28] Rituximab therapy for juvenile-onset systemic lupus erythematosus
    Obioma Nwobi
    Carolyn L. Abitbol
    Jayanthi Chandar
    Wacharee Seeherunvong
    Gastón Zilleruelo
    Pediatric Nephrology, 2008, 23 : 413 - 419
  • [29] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus
    Djabarouti, Sarah
    Duffau, Pierre
    Lazaro, Estibaliz
    Chapouly, Candice
    Greib, Carine
    Viallard, Jean-Francois
    Pellegrin, Jean-Luc
    Saux, Marie-Claude
    Breilh, Dominique
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) : 689 - 699
  • [30] Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study
    Nannini, C.
    Crowson, C. S.
    Matteson, E. L.
    Moder, K. G.
    LUPUS, 2009, 18 (05) : 394 - 399